Cornell N W, Hansch C, Kim K H, Henegar K
Arch Biochem Biophys. 1983 Nov;227(1):81-90. doi: 10.1016/0003-9861(83)90349-1.
As a means of comparing the functional properties of an enzyme in dilute solution in vitro with those for the same enzyme acting in its normal cellular environment, a study was conducted with 4-substituted pyrazoles as inhibitors of rat liver alcohol dehydrogenase in vitro and ethanol oxidation in isolated rat hepatocytes. Inhibitor constants (Ki's) for the same set of pyrazole derivatives were also determined for human liver alcohol dehydrogenase. The best-fitting equations were derived to relate the Ki's to the chemical nature of substituents. These quantitative structure-activity relationships show that pyrazoles with stronger electron-withdrawing substituents are weaker inhibitors both for the enzyme in vitro and, to an equal extent, for ethanol oxidation by intact cells. Inhibitor effectiveness is also dependent on substituent hydrophobicity, but, while increasing hydrophobicity makes stronger inhibitors of the enzyme in vitro, it can diminish the effectiveness in vivo by decreasing permeability through the cell membrane. A structure-activity analysis of published Ki's for pyrazoles acting against human pi-ADH indicates that its active site differs from those in other alcohol dehydrogenases.
为了比较一种酶在体外稀溶液中的功能特性与其在正常细胞环境中发挥作用时的功能特性,开展了一项研究,以4-取代吡唑作为大鼠肝脏乙醇脱氢酶的体外抑制剂,并研究其对分离的大鼠肝细胞中乙醇氧化的影响。还测定了同一组吡唑衍生物对人肝脏乙醇脱氢酶的抑制常数(Ki值)。推导出了最佳拟合方程,以将Ki值与取代基的化学性质联系起来。这些定量构效关系表明,具有较强吸电子取代基的吡唑对体外酶的抑制作用较弱,对完整细胞乙醇氧化的抑制作用也同样较弱。抑制剂的有效性还取决于取代基的疏水性,然而,虽然增加疏水性会使体外酶的抑制剂更强,但它可能会因降低细胞膜通透性而降低体内有效性。对已发表的吡唑作用于人π-ADH的Ki值进行的构效分析表明,其活性位点与其他乙醇脱氢酶的活性位点不同。